Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Abroad (travel likely)Recruiting
Conditions
Systemic Lupus Erythematosus (Sle) · Primary Ovarian Insufficiency (Poi)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland, United States
Study leads
Sarfaraz A Hasni, M.D.
Principal Investigator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)